Safety and tolerability of the hexadecapeptide AOD9604 in humans
Additional biomarker data from this cohort are expected in the first half of 2026
There was a clear correlation between the length of T2DM and brain atrophy, particularly for hippocampal atrophy, and the development of AD [26]
Approved by the FDA at the end of 2025 with a second product expected in April of this year, the oral GLP-1s are expected to open a new frontier for potential users including those hesitant to use injectable options
By reducing appetite, cravings, and excess calorie consumption, these medications may help lower household food costs while improving metabolic health
SeekPeptides members access detailed maintenance protocols and long-term strategy guides that help researchers transition from active fat loss phases into sustainable maintenance phases without losing their results